COVID-19 Impact on Global Biopharmaceutical and Vaccine Production Market Size, Status and Forecast 2020-2026
Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biopharmaceutical and Vaccine Production market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biopharmaceutical and Vaccine Production industry.
Based on our recent survey, we have several different scenarios about the Biopharmaceutical and Vaccine Production YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biopharmaceutical and Vaccine Production will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical and Vaccine Production market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical and Vaccine Production market in terms of revenue.
Players, stakeholders, and other participants in the global Biopharmaceutical and Vaccine Production market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biopharmaceutical and Vaccine Production market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biopharmaceutical and Vaccine Production market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical and Vaccine Production market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical and Vaccine Production market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biopharmaceutical and Vaccine Production market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biopharmaceutical and Vaccine Production industry.
Based on our recent survey, we have several different scenarios about the Biopharmaceutical and Vaccine Production YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biopharmaceutical and Vaccine Production will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical and Vaccine Production market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical and Vaccine Production market in terms of revenue.
Players, stakeholders, and other participants in the global Biopharmaceutical and Vaccine Production market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biopharmaceutical and Vaccine Production market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biopharmaceutical and Vaccine Production market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical and Vaccine Production market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical and Vaccine Production market.
The following players are covered in this report:
- Novartis
- Pfizer
- Sanofi
- Roche
- Abbott
- Regeneron Pharmaceuticals
- Alexion Pharmaceuticals
- Johnson and Johnson
- GlaxoSmithKline
- Merck
- Lonza
- FUJIFILM Diosynth Biotechnologies
- Biopharmaceutical
- Vaccine Production
- Pharmaceutical
- Biotechnology
- Academic and Research Institutes
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biopharmaceutical and Vaccine Production Revenue
1.4 Market Analysis by Type
1.4.1 Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biopharmaceutical
1.4.3 Vaccine Production
1.5 Market by Application
1.5.1 Global Biopharmaceutical and Vaccine Production Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical
1.5.3 Biotechnology
1.5.4 Academic and Research Institutes
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical and Vaccine Production Industry Impact
1.6.1 How the Covid-19 is Affecting the Biopharmaceutical and Vaccine Production Industry
1.6.1.1 Biopharmaceutical and Vaccine Production Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biopharmaceutical and Vaccine Production Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biopharmaceutical and Vaccine Production Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Biopharmaceutical and Vaccine Production Market Perspective (2015-2026)
2.2 Biopharmaceutical and Vaccine Production Growth Trends by Regions
2.2.1 Biopharmaceutical and Vaccine Production Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biopharmaceutical and Vaccine Production Historic Market Share by Regions (2015-2020)
2.2.3 Biopharmaceutical and Vaccine Production Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biopharmaceutical and Vaccine Production Market Growth Strategy
2.3.6 Primary Interviews with Key Biopharmaceutical and Vaccine Production Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Biopharmaceutical and Vaccine Production Players by Market Size
3.1.1 Global Top Biopharmaceutical and Vaccine Production Players by Revenue (2015-2020)
3.1.2 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Players (2015-2020)
3.1.3 Global Biopharmaceutical and Vaccine Production Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio
3.2.1 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccine Production Revenue in 2019
3.3 Biopharmaceutical and Vaccine Production Key Players Head office and Area Served
3.4 Key Players Biopharmaceutical and Vaccine Production Product Solution and Service
3.5 Date of Enter into Biopharmaceutical and Vaccine Production Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Type (2015-2020)
4.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2021-2026)
5 BIOPHARMACEUTICAL AND VACCINE PRODUCTION BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
5.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biopharmaceutical and Vaccine Production Market Size (2015-2020)
6.2 Biopharmaceutical and Vaccine Production Key Players in North America (2019-2020)
6.3 North America Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
6.4 North America Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Biopharmaceutical and Vaccine Production Market Size (2015-2020)
7.2 Biopharmaceutical and Vaccine Production Key Players in Europe (2019-2020)
7.3 Europe Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
7.4 Europe Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
8 CHINA
8.1 China Biopharmaceutical and Vaccine Production Market Size (2015-2020)
8.2 Biopharmaceutical and Vaccine Production Key Players in China (2019-2020)
8.3 China Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
8.4 China Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Biopharmaceutical and Vaccine Production Market Size (2015-2020)
9.2 Biopharmaceutical and Vaccine Production Key Players in Japan (2019-2020)
9.3 Japan Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
9.4 Japan Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Biopharmaceutical and Vaccine Production Market Size (2015-2020)
10.2 Biopharmaceutical and Vaccine Production Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
10.4 Southeast Asia Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
11 INDIA
11.1 India Biopharmaceutical and Vaccine Production Market Size (2015-2020)
11.2 Biopharmaceutical and Vaccine Production Key Players in India (2019-2020)
11.3 India Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
11.4 India Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Biopharmaceutical and Vaccine Production Market Size (2015-2020)
12.2 Biopharmaceutical and Vaccine Production Key Players in Central & South America (2019-2020)
12.3 Central & South America Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
12.4 Central & South America Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview and Its Total Revenue
13.1.3 Novartis Biopharmaceutical and Vaccine Production Introduction
13.1.4 Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer Biopharmaceutical and Vaccine Production Introduction
13.2.4 Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview and Its Total Revenue
13.3.3 Sanofi Biopharmaceutical and Vaccine Production Introduction
13.3.4 Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview and Its Total Revenue
13.4.3 Roche Biopharmaceutical and Vaccine Production Introduction
13.4.4 Roche Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview and Its Total Revenue
13.5.3 Abbott Biopharmaceutical and Vaccine Production Introduction
13.5.4 Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Regeneron Pharmaceuticals
13.6.1 Regeneron Pharmaceuticals Company Details
13.6.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction
13.6.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.6.5 Regeneron Pharmaceuticals Recent Development
13.7 Alexion Pharmaceuticals
13.7.1 Alexion Pharmaceuticals Company Details
13.7.2 Alexion Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction
13.7.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.7.5 Alexion Pharmaceuticals Recent Development
13.8 Johnson and Johnson
13.8.1 Johnson and Johnson Company Details
13.8.2 Johnson and Johnson Business Overview and Its Total Revenue
13.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Introduction
13.8.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.8.5 Johnson and Johnson Recent Development
13.9 GlaxoSmithKline
13.9.1 GlaxoSmithKline Company Details
13.9.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Introduction
13.9.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.9.5 GlaxoSmithKline Recent Development
13.10 Merck
13.10.1 Merck Company Details
13.10.2 Merck Business Overview and Its Total Revenue
13.10.3 Merck Biopharmaceutical and Vaccine Production Introduction
13.10.4 Merck Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.10.5 Merck Recent Development
13.11 Lonza
10.11.1 Lonza Company Details
10.11.2 Lonza Business Overview and Its Total Revenue
10.11.3 Lonza Biopharmaceutical and Vaccine Production Introduction
10.11.4 Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
10.11.5 Lonza Recent Development
13.12 FUJIFILM Diosynth Biotechnologies
10.12.1 FUJIFILM Diosynth Biotechnologies Company Details
10.12.2 FUJIFILM Diosynth Biotechnologies Business Overview and Its Total Revenue
10.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Introduction
10.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
10.12.5 FUJIFILM Diosynth Biotechnologies Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biopharmaceutical and Vaccine Production Revenue
1.4 Market Analysis by Type
1.4.1 Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biopharmaceutical
1.4.3 Vaccine Production
1.5 Market by Application
1.5.1 Global Biopharmaceutical and Vaccine Production Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical
1.5.3 Biotechnology
1.5.4 Academic and Research Institutes
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical and Vaccine Production Industry Impact
1.6.1 How the Covid-19 is Affecting the Biopharmaceutical and Vaccine Production Industry
1.6.1.1 Biopharmaceutical and Vaccine Production Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biopharmaceutical and Vaccine Production Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biopharmaceutical and Vaccine Production Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Biopharmaceutical and Vaccine Production Market Perspective (2015-2026)
2.2 Biopharmaceutical and Vaccine Production Growth Trends by Regions
2.2.1 Biopharmaceutical and Vaccine Production Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biopharmaceutical and Vaccine Production Historic Market Share by Regions (2015-2020)
2.2.3 Biopharmaceutical and Vaccine Production Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biopharmaceutical and Vaccine Production Market Growth Strategy
2.3.6 Primary Interviews with Key Biopharmaceutical and Vaccine Production Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Biopharmaceutical and Vaccine Production Players by Market Size
3.1.1 Global Top Biopharmaceutical and Vaccine Production Players by Revenue (2015-2020)
3.1.2 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Players (2015-2020)
3.1.3 Global Biopharmaceutical and Vaccine Production Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio
3.2.1 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccine Production Revenue in 2019
3.3 Biopharmaceutical and Vaccine Production Key Players Head office and Area Served
3.4 Key Players Biopharmaceutical and Vaccine Production Product Solution and Service
3.5 Date of Enter into Biopharmaceutical and Vaccine Production Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Type (2015-2020)
4.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2021-2026)
5 BIOPHARMACEUTICAL AND VACCINE PRODUCTION BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
5.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Biopharmaceutical and Vaccine Production Market Size (2015-2020)
6.2 Biopharmaceutical and Vaccine Production Key Players in North America (2019-2020)
6.3 North America Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
6.4 North America Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Biopharmaceutical and Vaccine Production Market Size (2015-2020)
7.2 Biopharmaceutical and Vaccine Production Key Players in Europe (2019-2020)
7.3 Europe Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
7.4 Europe Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
8 CHINA
8.1 China Biopharmaceutical and Vaccine Production Market Size (2015-2020)
8.2 Biopharmaceutical and Vaccine Production Key Players in China (2019-2020)
8.3 China Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
8.4 China Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Biopharmaceutical and Vaccine Production Market Size (2015-2020)
9.2 Biopharmaceutical and Vaccine Production Key Players in Japan (2019-2020)
9.3 Japan Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
9.4 Japan Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Biopharmaceutical and Vaccine Production Market Size (2015-2020)
10.2 Biopharmaceutical and Vaccine Production Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
10.4 Southeast Asia Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
11 INDIA
11.1 India Biopharmaceutical and Vaccine Production Market Size (2015-2020)
11.2 Biopharmaceutical and Vaccine Production Key Players in India (2019-2020)
11.3 India Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
11.4 India Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Biopharmaceutical and Vaccine Production Market Size (2015-2020)
12.2 Biopharmaceutical and Vaccine Production Key Players in Central & South America (2019-2020)
12.3 Central & South America Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020)
12.4 Central & South America Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview and Its Total Revenue
13.1.3 Novartis Biopharmaceutical and Vaccine Production Introduction
13.1.4 Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer Biopharmaceutical and Vaccine Production Introduction
13.2.4 Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview and Its Total Revenue
13.3.3 Sanofi Biopharmaceutical and Vaccine Production Introduction
13.3.4 Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview and Its Total Revenue
13.4.3 Roche Biopharmaceutical and Vaccine Production Introduction
13.4.4 Roche Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview and Its Total Revenue
13.5.3 Abbott Biopharmaceutical and Vaccine Production Introduction
13.5.4 Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Regeneron Pharmaceuticals
13.6.1 Regeneron Pharmaceuticals Company Details
13.6.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction
13.6.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.6.5 Regeneron Pharmaceuticals Recent Development
13.7 Alexion Pharmaceuticals
13.7.1 Alexion Pharmaceuticals Company Details
13.7.2 Alexion Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction
13.7.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.7.5 Alexion Pharmaceuticals Recent Development
13.8 Johnson and Johnson
13.8.1 Johnson and Johnson Company Details
13.8.2 Johnson and Johnson Business Overview and Its Total Revenue
13.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Introduction
13.8.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.8.5 Johnson and Johnson Recent Development
13.9 GlaxoSmithKline
13.9.1 GlaxoSmithKline Company Details
13.9.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Introduction
13.9.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.9.5 GlaxoSmithKline Recent Development
13.10 Merck
13.10.1 Merck Company Details
13.10.2 Merck Business Overview and Its Total Revenue
13.10.3 Merck Biopharmaceutical and Vaccine Production Introduction
13.10.4 Merck Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
13.10.5 Merck Recent Development
13.11 Lonza
10.11.1 Lonza Company Details
10.11.2 Lonza Business Overview and Its Total Revenue
10.11.3 Lonza Biopharmaceutical and Vaccine Production Introduction
10.11.4 Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
10.11.5 Lonza Recent Development
13.12 FUJIFILM Diosynth Biotechnologies
10.12.1 FUJIFILM Diosynth Biotechnologies Company Details
10.12.2 FUJIFILM Diosynth Biotechnologies Business Overview and Its Total Revenue
10.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Introduction
10.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020)
10.12.5 FUJIFILM Diosynth Biotechnologies Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Biopharmaceutical and Vaccine Production Key Market Segments
Table 2. Key Players Covered: Ranking by Biopharmaceutical and Vaccine Production Revenue
Table 3. Ranking of Global Top Biopharmaceutical and Vaccine Production Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biopharmaceutical
Table 6. Key Players of Vaccine Production
Table 7. COVID-19 Impact Global Market: (Four Biopharmaceutical and Vaccine Production Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Biopharmaceutical and Vaccine Production Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Biopharmaceutical and Vaccine Production Players to Combat Covid-19 Impact
Table 12. Global Biopharmaceutical and Vaccine Production Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Biopharmaceutical and Vaccine Production Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Biopharmaceutical and Vaccine Production Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Biopharmaceutical and Vaccine Production Market Share by Regions (2015-2020)
Table 16. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Biopharmaceutical and Vaccine Production Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Biopharmaceutical and Vaccine Production Market Growth Strategy
Table 22. Main Points Interviewed from Key Biopharmaceutical and Vaccine Production Players
Table 23. Global Biopharmaceutical and Vaccine Production Revenue by Players (2015-2020) (Million US$)
Table 24. Global Biopharmaceutical and Vaccine Production Market Share by Players (2015-2020)
Table 25. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2019)
Table 26. Global Biopharmaceutical and Vaccine Production by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Biopharmaceutical and Vaccine Production Product Solution and Service
Table 29. Date of Enter into Biopharmaceutical and Vaccine Production Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 32. Global Biopharmaceutical and Vaccine Production Market Size Share by Type (2015-2020)
Table 33. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2021-2026)
Table 34. Global Biopharmaceutical and Vaccine Production Market Size Share by Application (2015-2020)
Table 35. Global Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 36. Global Biopharmaceutical and Vaccine Production Market Size Share by Application (2021-2026)
Table 37. North America Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 39. North America Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 40. North America Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 41. North America Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 42. North America Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 43. Europe Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 45. Europe Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 47. Europe Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 49. China Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 50. China Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 51. China Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 52. China Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 53. China Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 54. China Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 55. Japan Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 57. Japan Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 59. Japan Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 63. Southeast Asia Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 65. Southeast Asia Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 67. India Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 68. India Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 69. India Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 70. India Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 71. India Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 72. India Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 75. Central & South America Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 77. Central & South America Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Product
Table 92. Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 93. Sanofi Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Product
Table 97. Roche Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 98. Roche Recent Development
Table 99. Abbott Company Details
Table 100. Abbott Business Overview
Table 101. Abbott Product
Table 102. Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 103. Abbott Recent Development
Table 104. Regeneron Pharmaceuticals Company Details
Table 105. Regeneron Pharmaceuticals Business Overview
Table 106. Regeneron Pharmaceuticals Product
Table 107. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 108. Regeneron Pharmaceuticals Recent Development
Table 109. Alexion Pharmaceuticals Company Details
Table 110. Alexion Pharmaceuticals Business Overview
Table 111. Alexion Pharmaceuticals Product
Table 112. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 113. Alexion Pharmaceuticals Recent Development
Table 114. Johnson and Johnson Business Overview
Table 115. Johnson and Johnson Product
Table 116. Johnson and Johnson Company Details
Table 117. Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 118. Johnson and Johnson Recent Development
Table 119. GlaxoSmithKline Company Details
Table 120. GlaxoSmithKline Business Overview
Table 121. GlaxoSmithKline Product
Table 122. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 123. GlaxoSmithKline Recent Development
Table 124. Merck Company Details
Table 125. Merck Business Overview
Table 126. Merck Product
Table 127. Merck Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 128. Merck Recent Development
Table 129. Lonza Company Details
Table 130. Lonza Business Overview
Table 131. Lonza Product
Table 132. Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 133. Lonza Recent Development
Table 134. FUJIFILM Diosynth Biotechnologies Company Details
Table 135. FUJIFILM Diosynth Biotechnologies Business Overview
Table 136. FUJIFILM Diosynth Biotechnologies Product
Table 137. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 138. FUJIFILM Diosynth Biotechnologies Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 1. Biopharmaceutical and Vaccine Production Key Market Segments
Table 2. Key Players Covered: Ranking by Biopharmaceutical and Vaccine Production Revenue
Table 3. Ranking of Global Top Biopharmaceutical and Vaccine Production Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biopharmaceutical
Table 6. Key Players of Vaccine Production
Table 7. COVID-19 Impact Global Market: (Four Biopharmaceutical and Vaccine Production Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Biopharmaceutical and Vaccine Production Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Biopharmaceutical and Vaccine Production Players to Combat Covid-19 Impact
Table 12. Global Biopharmaceutical and Vaccine Production Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Biopharmaceutical and Vaccine Production Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Biopharmaceutical and Vaccine Production Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Biopharmaceutical and Vaccine Production Market Share by Regions (2015-2020)
Table 16. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Biopharmaceutical and Vaccine Production Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Biopharmaceutical and Vaccine Production Market Growth Strategy
Table 22. Main Points Interviewed from Key Biopharmaceutical and Vaccine Production Players
Table 23. Global Biopharmaceutical and Vaccine Production Revenue by Players (2015-2020) (Million US$)
Table 24. Global Biopharmaceutical and Vaccine Production Market Share by Players (2015-2020)
Table 25. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2019)
Table 26. Global Biopharmaceutical and Vaccine Production by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Biopharmaceutical and Vaccine Production Product Solution and Service
Table 29. Date of Enter into Biopharmaceutical and Vaccine Production Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 32. Global Biopharmaceutical and Vaccine Production Market Size Share by Type (2015-2020)
Table 33. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2021-2026)
Table 34. Global Biopharmaceutical and Vaccine Production Market Size Share by Application (2015-2020)
Table 35. Global Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 36. Global Biopharmaceutical and Vaccine Production Market Size Share by Application (2021-2026)
Table 37. North America Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 39. North America Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 40. North America Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 41. North America Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 42. North America Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 43. Europe Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 45. Europe Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 47. Europe Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 49. China Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 50. China Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 51. China Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 52. China Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 53. China Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 54. China Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 55. Japan Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 57. Japan Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 59. Japan Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 63. Southeast Asia Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 65. Southeast Asia Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 67. India Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 68. India Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 69. India Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 70. India Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 71. India Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 72. India Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Biopharmaceutical and Vaccine Production Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Biopharmaceutical and Vaccine Production Market Share (2019-2020)
Table 75. Central & South America Biopharmaceutical and Vaccine Production Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Biopharmaceutical and Vaccine Production Market Share by Type (2015-2020)
Table 77. Central & South America Biopharmaceutical and Vaccine Production Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Biopharmaceutical and Vaccine Production Market Share by Application (2015-2020)
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Product
Table 92. Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 93. Sanofi Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Product
Table 97. Roche Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 98. Roche Recent Development
Table 99. Abbott Company Details
Table 100. Abbott Business Overview
Table 101. Abbott Product
Table 102. Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 103. Abbott Recent Development
Table 104. Regeneron Pharmaceuticals Company Details
Table 105. Regeneron Pharmaceuticals Business Overview
Table 106. Regeneron Pharmaceuticals Product
Table 107. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 108. Regeneron Pharmaceuticals Recent Development
Table 109. Alexion Pharmaceuticals Company Details
Table 110. Alexion Pharmaceuticals Business Overview
Table 111. Alexion Pharmaceuticals Product
Table 112. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 113. Alexion Pharmaceuticals Recent Development
Table 114. Johnson and Johnson Business Overview
Table 115. Johnson and Johnson Product
Table 116. Johnson and Johnson Company Details
Table 117. Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 118. Johnson and Johnson Recent Development
Table 119. GlaxoSmithKline Company Details
Table 120. GlaxoSmithKline Business Overview
Table 121. GlaxoSmithKline Product
Table 122. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 123. GlaxoSmithKline Recent Development
Table 124. Merck Company Details
Table 125. Merck Business Overview
Table 126. Merck Product
Table 127. Merck Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 128. Merck Recent Development
Table 129. Lonza Company Details
Table 130. Lonza Business Overview
Table 131. Lonza Product
Table 132. Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 133. Lonza Recent Development
Table 134. FUJIFILM Diosynth Biotechnologies Company Details
Table 135. FUJIFILM Diosynth Biotechnologies Business Overview
Table 136. FUJIFILM Diosynth Biotechnologies Product
Table 137. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2015-2020) (Million US$)
Table 138. FUJIFILM Diosynth Biotechnologies Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Biopharmaceutical and Vaccine Production Market Share by Type: 2020 VS 2026
Figure 2. Biopharmaceutical Features
Figure 3. Vaccine Production Features
Figure 4. Global Biopharmaceutical and Vaccine Production Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical Case Studies
Figure 6. Biotechnology Case Studies
Figure 7. Academic and Research Institutes Case Studies
Figure 8. Others Case Studies
Figure 9. Biopharmaceutical and Vaccine Production Report Years Considered
Figure 10. Global Biopharmaceutical and Vaccine Production Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Biopharmaceutical and Vaccine Production Market Share by Regions: 2020 VS 2026
Figure 12. Global Biopharmaceutical and Vaccine Production Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Biopharmaceutical and Vaccine Production Market Share by Players in 2019
Figure 15. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccine Production Revenue in 2019
Figure 17. North America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 32. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 34. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 36. Alexion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 38. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 40. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 42. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Merck Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 44. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 46. FUJIFILM Diosynth Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Figure 1. Global Biopharmaceutical and Vaccine Production Market Share by Type: 2020 VS 2026
Figure 2. Biopharmaceutical Features
Figure 3. Vaccine Production Features
Figure 4. Global Biopharmaceutical and Vaccine Production Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical Case Studies
Figure 6. Biotechnology Case Studies
Figure 7. Academic and Research Institutes Case Studies
Figure 8. Others Case Studies
Figure 9. Biopharmaceutical and Vaccine Production Report Years Considered
Figure 10. Global Biopharmaceutical and Vaccine Production Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Biopharmaceutical and Vaccine Production Market Share by Regions: 2020 VS 2026
Figure 12. Global Biopharmaceutical and Vaccine Production Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Biopharmaceutical and Vaccine Production Market Share by Players in 2019
Figure 15. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccine Production Revenue in 2019
Figure 17. North America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 32. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 34. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 36. Alexion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 38. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 40. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 42. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Merck Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 44. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 46. FUJIFILM Diosynth Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
